MERTK and type 1 diabetes mellitus: Findings by Lindsay et al. indicate that MerTK in monocytes from the pancreatic islets regulates T cell activation in type 1 diabetes and melanoma, leading to decreased T cell scanning sensitivity for cognate antigen [38].